• Home
  • Contact Us
  • Sitemap
  • About Aveo
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Careers
  • Product Candidates
    • Overview
    • Tivozanib (AV-951)
    • • TIVO-1
    • AV-299
    • AV-203
    • For Patients
  • Discovery Programs
    • Overview
    • FGF Program
    • Notch Program
    • RON Program
  • Our Platform
    • Platform Overview
  • Partnering
    • Our Approach
    • Our Partners
    • Areas of Interest
  • Partnering
  • Overview
  • Press Releases
  • Events
  • Publications and Presentations

Media Contact:

Caton Lovett

Pure Communications

contact via email

(910) 232-7166

 

« Go Back

CEO of AVEO Pharmaceuticals Discusses Testing Stategies in a Life Sciences Report on NECN

June 18th, 2009

CEO of AVEO Pharmaceuticals Discusses

Testing Stategies in a Life Sciences Report on NECN

 

CEO of AVEO Pharmaceuticals, Tuan Ha-Ngoc, discusses AVEO’s cancer biology platform and clinical development strategies on NECN in a segment titled Life Sciences Report on Wednesday, June 17, 2009. Click here http://www.necn.com/Boston/Business/2009/06/17/CEO-of-AVEO-Pharmaceuticals/1245280462.html to view the link.

 

 

 
 

© 2010 AVEO Pharmaceuticals, Inc. All rights reserved.

  • Home
  • Contact Us
  • Sitemap
  • Terms
  • Privacy
  •   |  
  • For Patients
  • For Physicians
  • Careers